
Founded on August 28, 1987, Guoxin Health Protection Service Group Corporation ("Guoxin Health") is a company specializing in the field of health protection services. The company's scope of business includes asset management (excluding financial assets), investment planning and consulting services, production and sales of chemical fibers, textiles and apparel, development of tourism resources, e-commerce network operation, network information services, information service business in the second category of value-added telecommunication services (excluding fixed-network telephony information services), investment in network engineering projects, network project design, installation, maintenance, technology development and transfer, network software, hardware and ancillary services. transfer, network software, hardware and supporting equipment, components, books and other sales.
Guoxin Health has remarkable strength in the field of medical informatization, and its self-developed and intellectual property rights "four banks and twenty-four systems" and "1+1+N" big data platform for healthcare protection services are in a leading position in the industry. At present, the company's business has covered 155 integrated regions in 24 provinces, involving 40,880 designated medical institutions and 65,781 designated pharmacies at all levels, and processing nearly 800 million medical visits and 70 billion pieces of diagnosis and treatment data annually.medical insuranceThe scale of fee control reaches 500 billion dollars, involving 270 million participants, and the market share is the first in the country.
In addition, Guoxin Health also actively promotes the construction and application of the intelligent audit platform for the health insurance fund, which has covered 50 municipalities in 17 provinces (autonomous regions and municipalities directly under the central government) nationwide, realizing the refined management of health insurance. The company is also committed to promoting advanced health insurance payment methods such as the DRGs point method, which has been successfully implemented in a number of regions.
In terms of operation, Guoxin Health focuses on synergistic development with its partners and has established cooperative relationships with a number of medical institutions and technology enterprises to jointly promote the development of medical informatization. At the same time, the company also actively fulfills its social responsibility and makes positive contributions to improving the level of China's medical security and service quality.
Overall, Guoxin Health is a leading company in the field of healthcare information technology, with a wide range of business scope, strong technological strength and market competitiveness, and is one of the key players in the field of healthcare insurance services.
data statistics
Relevant Navigation

Focused on leveraging AI algorithms and genetic technologies, particularly in RNA research, to jointly drive innovative drug discovery and development to address long-unmet clinical needs in areas such as oncology, infections and rare diseases.

Changmu Valley
A national high-tech enterprise focusing on orthopaedic artificial intelligence and surgical robotics solutions, it provides full-process intelligent solutions from pre-operative planning to post-operative evaluation, and is committed to promoting the precision, standardization and intelligence of orthopaedic surgery.

InSilicon Intelligence
Focuses on utilizing generative artificial intelligence to accelerate drug discovery and development, especially comprehensive solutions in target discovery, drug molecule generation and clinical trial prediction.

TuiXiang Medical
A high-tech enterprise focusing on AI healthcare, dedicated to improving global life health through artificial intelligence technology and providing advanced intelligent medical integration services.

Yidu Tech
A company specializing in healthcare big data solutions, providing comprehensive support for medical research, healthcare management, regional public health and population health management, and innovative drug development through big data and artificial intelligence technologies.

Zhitai Pharmaceutical
A leading global AI-powered drug delivery and drug discovery biotechnology company dedicated to driving innovative drug development and addressing unmet clinical needs more efficiently and accurately through AI technology.

Zuo Shou Yi Sheng
A company that utilizes AI technology to provide smart healthcare solutions and is dedicated to improving the efficiency and quality of healthcare services through deep learning, natural language processing, and other technologies.

Zero Hypothesis
Focusing on the use of advanced AI technology to provide high-quality, professional medical content generation and search solutions for the healthcare industry, to promote the dissemination and application of medical knowledge.
No comments...